Publications by authors named "Harry Bleiberg"

Claim this Profile
T
Too little benefit for too much toxicity: rethinking the adjuvant development model in colon cancer.
Alain Hendlisz, Harry Bleiberg

Curr Opin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.
Driss Ait Ouakrim, Cécile Pizot, Magali Boniol, Matteo Malvezzi, Mathieu Boniol, Harry Bleiberg

BMJ· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.
Xavier Paoletti, Koji Oba, Yung-Jue Bang, Harry Bleiberg, Narikazu Boku

J Natl Cancer Inst· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.
Koji Oba, Xavier Paoletti, Steven Alberts, Yung-Jue Bang, Jacqueline Benedetti, Harry Bleiberg

J Natl Cancer Inst· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Eur J Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical models to discriminate between benign and malignant adnexal masses: potential diagnostic improvement using ovarian HistoScanning.
Evelien Vaes, Ranjit Manchanda, Rina Nir, Dror Nir, Harry Bleiberg

Int J Gynecol Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study.
Olivier Lucidarme, Jean-Paul Akakpo, Seth Granberg, Mario Sideri, Hanoch Levavi, Harry Bleiberg

Eur Radiol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers.
Johan Braeckman, Philippe Autier, Cristina Soviany, Rina Nir, Dror Nir, Harry Bleiberg

BJU Int· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.
Emmanuel Mitry, Anthony L A Fields, Harry Bleiberg, Roberto Labianca, Guillaume Portier

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer.
Johan Braeckman, Philippe Autier, Christian Garbar, Miriam Pipeleers Marichal, Cristina Soviany, Harry Bleiberg

BJU Int· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing older patients with colorectal cancer.
Hanna Kelly Sanoff, Harry Bleiberg, Richard M Goldberg

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases.
Nathalie Baize, Béatrice Gerard, Harry Bleiberg, François Caroli-Bosc, Frédéric Berthier

Gastroenterol Clin Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.
Daniela D Rosa, Gustavo F V Ismael, Evandro de Azambuja, Sofia Braga, Fatima Cardoso, Harry Bleiberg

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
Richard M Goldberg, Isabelle Tabah-Fisch, Harry Bleiberg, Aimery de Gramont, Christophe Tournigand

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we cautious enough when we interpret results of randomized but underpowered comparisons?
Marianne Paesmans, Harry Bleiberg

J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Roy S Herbst, Dean F Bajorin, Harry Bleiberg, Diane Blum, Desirée Hao

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer.
Nicola Personeni, Alain Hendlisz, Julien Gallez, Maria Gomez Galdon, Denis Larsimont, Harry Bleiberg

Semin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment of colon cancer.
Harry Bleiberg

Curr Opin Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
Bernard Nordlinger, Philippe Rougier, Jean-Pierre Arnaud, Muriel Debois, Jaques Wils, Harry Bleiberg

Lancet Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg

N Engl J Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatocarcinoma.
Beatrice Gerard, Harry Bleiberg

Curr Oncol Rep· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is FOB screening really the answer for lowering mortality in colorectal cancer?
Philippe Autier, Peter Boyle, Marc Buyse, Harry Bleiberg

Recent Results Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer.
Angelo Di Leo, Harry Bleiberg, Marc Buyse

J Clin Oncol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced colorectal cancer treatment in Europe: what have we achieved?
Harry Bleiberg, Alain Hendlisz

Anticancer Drugs· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
Harry Bleiberg, Angelo Di Leo

J Clin Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis